Lifestance Health Group Inc
NASDAQ: LFST · HEALTHCARE · MEDICAL CARE FACILITIES
Updated 2026-04-29
Lifestance Health Group Inc (LFST) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for LFST.
Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.
LFST historical valuation range
Where current P/E sits in LFST's own 5Y range.
LFST intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
LFST valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 371.50x
P/S Ratio — History
Current: 2.02x
Is LFST overvalued in 2026?
Lifestance Health Group Inc (LFST) currently trades at $7.43 per share with a market capitalization of $2,881,560,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 42/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 371.5x.
Our discounted cash flow model estimates LFST's intrinsic value at $15.06 per share, against the current market price of $7.43. This implies a margin of safety of +53.98%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
Financial quality is a concern. The Piotroski F-Score of 0/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: LFST appears richly valued on our framework, with a Smart Value Score of 42/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.
Frequently asked questions
Is LFST overvalued in 2026?
Based on a Smart Value Score of 42/100, LFST appears overvalued. Current price exceeds what fundamentals currently justify.
What is LFST's fair value?
Our DCF model estimates LFST's intrinsic value at $15.06 per share, versus the current price of $7.43. This produces a margin of safety of +53.98%.
What P/E ratio does LFST trade at?
LFST trades at a P/E of 371.5x on trailing twelve-month earnings.
Is LFST a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 42/100 reflects the combined read on growth, quality, and price. The profile skews cautious. Consider waiting for a better price or clearer operational improvement.
How does LFST's valuation compare to its history?
Insufficient historical valuation data exists yet for a confident percentile read on LFST.
What is LFST's Smart Value Score?
LFST's Smart Value Score is 42/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.